Rank | Holder | SharesFloat % | Change | Date reported |
---|---|---|---|---|
1 | BlackRock Inc | 7.91M (9.30%) | 354.33K Increased by +4.48% | Jun 30, 24 |
2 | Wellington Management Company LLP | 7.34M (8.63%) | -97.61K Decreased by -1.33% | Jun 30, 24 |
3 | Kynam Capital Management, LP | 5.84M (6.87%) | 120.87K Increased by +2.07% | Sep 30, 24 |
4 | Vanguard Group Inc | 4.89M (5.75%) | 89.89K Increased by +1.84% | Sep 30, 24 |
5 | State Street Corporation | 4.82M (5.67%) | -196.63K Decreased by -4.08% | Mar 31, 24 |
6 | Eversept Partners, LLC | 4.11M (4.83%) | 491.68K Increased by +11.98% | Sep 30, 24 |
7 | venBio Select Advisor LLC | 3.89M (4.57%) | 0.00 Increased by 0.00% | Sep 30, 24 |
8 | State Street Corp | 3.62M (4.26%) | -1.20M Decreased by -33.05% | Jun 30, 24 |
9 | Avidity Partners Management LP | 3.33M (3.92%) | 922.50K Increased by +27.66% | Jun 30, 24 |
10 | Point72 Asset Management, L.P. | 2.78M (3.27%) | 716.17K Increased by +25.74% | Jun 30, 24 |
11 | Partner Fund Management LP | 2.72M (3.19%) | 542.80K Increased by +19.99% | Sep 30, 23 |
12 | Hudson Bay Capital Management LP | 2.47M (2.91%) | 2.00M Increased by +80.79% | Sep 30, 23 |
13 | T. Rowe Price Investment Management,Inc. | 2.46M (2.89%) | -252.02K Decreased by -10.25% | Mar 31, 24 |
14 | Paradigm Biocapital Advisors LP | 2.39M (2.81%) | -34.05K Decreased by -1.42% | Sep 30, 23 |
15 | Jennison Associates LLC | 2.35M (2.76%) | -174.24K Decreased by -7.42% | Sep 30, 23 |
16 | Sofinnova Ventures | 2.15M (2.53%) | 545.13K Increased by +25.31% | Jun 30, 24 |
17 | Orbimed Advisors, LLC | 1.93M (2.26%) | 176.30K Increased by +9.16% | Jun 30, 24 |
18 | Geode Capital Management, LLC | 1.91M (2.25%) | 132.07K Increased by +6.91% | Jun 30, 24 |
19 | Bvf Inc | 1.88M (2.21%) | 1.88M Increased by +100.00% | Mar 31, 24 |
20 | Marshall Wace Asset Management Ltd | 1.83M (2.15%) | -201.63K Decreased by -11.02% | Jun 30, 24 |
Rank | Holder | SharesFloat % | Change | Date reported |
---|---|---|---|---|
1 | Vanguard Health Care Inv | 2.99M (3.51%) | -1.26M Decreased by -42.24% | Sep 30, 24 |
2 | Vanguard Total Stock Mkt Idx Inv | 2.57M (3.02%) | -30.12K Decreased by -1.17% | Oct 31, 24 |
3 | iShares Russell 2000 ETF | 2.13M (2.50%) | -4.79K Decreased by -0.23% | Oct 31, 24 |
4 | SPDR® S&P Biotech ETF | 1.84M (2.17%) | -26.63K Decreased by -1.44% | Oct 31, 24 |
5 | Vanguard Institutional Extnd Mkt Idx Tr | 1.26M (1.48%) | 18.22K Increased by +1.45% | Sep 30, 24 |
6 | Fidelity Small Cap Index | 841.55K (0.99%) | -20.66K Decreased by -2.46% | Aug 31, 24 |
7 | Franklin Biotechnology Discv A(acc)USD | 733.21K (0.86%) | 148.00K Increased by +20.19% | Sep 30, 24 |
8 | iShares Russell 2000 Growth ETF | 730.98K (0.86%) | 0.00 Increased by 0.00% | Oct 31, 24 |
9 | Biotech Growth Ord | 637.20K (0.75%) | 0.00 Increased by 0.00% | Jul 31, 24 |
10 | Fidelity® Small Cap Index | 634.70K (0.75%) | 15.84K Increased by +2.50% | Oct 31, 23 |
11 | Wellington Global Hlthcr Eq USD G Ac | 633.83K (0.75%) | -13.65K Decreased by -2.15% | May 31, 24 |
12 | T. Rowe Price Small-Cap Value | 607.50K (0.71%) | -270.60K Decreased by -44.54% | Mar 31, 24 |
13 | Franklin Small Cap Growth Adv | 566.58K (0.67%) | 0.00 Increased by 0.00% | Sep 30, 24 |
14 | Franklin US Small Cap Growth Equity | 566.58K (0.67%) | -5.82K Decreased by -1.03% | Sep 30, 24 |
15 | iShares Biotechnology ETF | 558.81K (0.66%) | -3.34K Decreased by -0.60% | Oct 31, 24 |
16 | State St Russell Sm/Mid Cp® Indx NL Cl C | 528.74K (0.62%) | -18.00K Decreased by -3.40% | Oct 31, 24 |
17 | Federated Hermes Kaufmann Growth | 522.40K (0.61%) | 272.40K Increased by +52.14% | Sep 30, 24 |
18 | Federated Hermes Kaufmann R | 522.40K (0.61%) | 272.40K Increased by +52.14% | Sep 30, 24 |
19 | Belfius Equities Cure C Cap | 513.51K (0.60%) | 0.00 Increased by 0.00% | Sep 30, 24 |
20 | Candriam Global Equities Oncology | 513.51K (0.60%) | 28.51K Increased by +5.55% | Sep 30, 24 |